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Abstract
Background: Principles of brain plasticity is used in the treatment of patients with functional
limitations to improve sensorimotor function. Training is included in the treatment of knee injury
to improve both patient-reported function and sensorimotor function. However, impairment in
sensorimotor function often persists despite training. Therefore, it was suggested that training
programs need to be more effective to improve sensorimotor function after knee injury. The aim
of the current study was to investigate if principles of brain plasticity that have been successfully
used on the hand and foot to improve sensorimotor function can be applied on the knee. We
hypothesized that temporary anesthesia of the skin area above and below the knee would improve
sensorimotor function of the ipsilateral knee and leg.
Methods: In this first double-blind exploratory study, 28 uninjured subjects (mean age 26 years,
range 19–34, 50% women) were randomized to temporary local cutaneous application of
anesthetic (EMLA®) (n = 14) or placebo cream (n = 14). Fifty grams of EMLA, or placebo, was
applied on the leg 10 cm above and 10 cm below the center of patella, leaving the area around the
knee without cream. Measures of sensory function (perception of touch, vibration sense, knee
kinesthesia) and motor function (knee muscle strength, hop test) were assessed before and after
90 minutes of treatment with EMLA or placebo. The paired t-test was used for comparisons within
groups and the independent t-test for comparisons between groups. The number of subjects
needed was determined by an a priori sample size calculation.
Results: No statistically significant or clinically relevant differences were seen over time (before
vs. after) in the measures of sensory or motor functions in the EMLA group or in the placebo group.
There were no differences between the groups due to treatment effect (EMLA vs. placebo).
Conclusion: We found no effect of temporary cutaneous anesthesia on sensorimotor function of
the ipsilateral knee and leg in uninjured subjects. The principles used in this study remain to be
tested in subjects with knee injury.
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Neuromuscular and/or strength training is included in the
treatment of knee injury and knee osteoarthritis (OA) to
improve both patient-reported function and objective
function, such as joint range of motion and sensorimotor
(neuromuscular) function. However, impairment in sen-
sorimotor function often persists after knee injury and
knee OA despite training [1-3]. It has been suggested that
good sensorimotor function is of importance for reducing
the risk of knee injury [4,5], for achieving better objective
and patient-reported knee function after injury [6,7], and
in preventing or slowing the progression of OA [8,2]. Lon-
gitudinal, prospective studies show that poor muscle
function, such as muscle weakness, is a predictor of OA
development [9-11]. In this perspective, treatment leading
to improved sensorimotor function would be of value for
patients with knee injury or OA in the short and long
term.
One of the most interesting questions in neuroscience
concerns the manner in which the nervous system can
modify its organization and ultimately its function
throughout an individual's lifetime based on sensory
input, experience, learning and injury[12,13]. This phe-
nomenon is often referred to as brain plasticity [14,15].
Plasticity changes can be divided into rapid and long term
plasticity. Rapid changes are typically seen minutes after
injury or intervention, and are often based on decreased
inhibition. Decreased inhibition increases the receptive
field size and enables more neurons to be activated by a
specific stimulus. This is sometimes referred to as unmask-
ing of synapses or neural structures. Long-term changes
are typically seen weeks or months after an injury or inter-
vention and are based on increase or decrease in synaptic
transmission or axonal and dendritic sprouting. Synaptic
transmission becomes facilitated in a pathway that is fre-
quently used, while those that lay dormant atrophy.
Sprouting can be seen in response to injury or to increased
functional demand [16]. Axons at the edges of a lesion
send new axonal branches into the damaged area and re-
innervate dendrites that have lost their synaptic input.
Plasticity changes also include changes in nerve signal
amplitude and activation of additional cortical areas
[14,15].
The primary motor (M1) and sensory (S1) cortex is organ-
ized somatotopically, where different body parts project
to different parts of the M1 and S1. The somatotopic map
does not represent the body in its actual proportions
[17,18]. Instead, larger cortical areas are being assigned to
sensitive parts or parts with complex motor demands such
as the hands and face [19,20]. The cortical representation
of different body parts changes constantly, depending on
the pattern of afferent nerve impulses, injury and
increased or decreased use [21-23]. For example, the fore-
arm is located next to the hand in the somatotopic map
[17,18] and by anaesthetizing the forearm, the cortical
hand area can expand over the forearm area [24]. Thus,
more nerve cells can be available for the hand, resulting in
improved hand function. To utilize the central nervous
systems' (CNS) ability to change for therapeutic purposes,
guided plasticity [25] is an attractive concept with prom-
ising results. The potential for cerebral plasticity is, for
example, used in treatment of patients to strengthen or
promote CNS functions that are lost or weakened [26].
Temporary cutaneous anesthesia of the volar aspect of the
forearm, using an anesthetic cream (EMLA®), resulted in
improved sensory function of the hand in healthy con-
trols [27]. In a randomized controlled trial (RCT), sensory
re-learning training in combination with cutaneous fore-
arm anesthesia improved sensory function of the hand
compared with sensory re-learning training and placebo
in patients with ulnar or median nerve repair [28]. The
participants received treatment twice a week for two con-
secutive weeks, and the effects lasted 4 weeks after the last
EMLA treatment. These results suggest that sensory recov-
ery is enhanced by combining training with temporary
anesthesia of adjacent body parts. The long lasting effect
indicates that this treatment is clinically useful and rele-
vant.
Recently, the same principle of temporary cutaneous
anesthesia as that used for the hand has been applied on
the foot in uninjured subjects [29]. In this RCT, improve-
ment in sensory function of the foot was observed after
cutaneous anesthesia of the lower leg compared with pla-
cebo [29]. To our knowledge, the principle of temporary
cutaneous anesthesia in improving sensorimotor function
of the knee has not yet been tested.
In this first study of a series of experiments, we included
subjects without injury. The aim of the current study was
to investigate if the principle of brain plasticity that has
been successfully used on the hand [27,28] and foot [29]
to improve sensory function, can be applied on the knee.
We hypothesized that temporary anesthesia of the skin
area above and below the knee would improve sensorim-
otor function of the ipsilateral knee and leg.
Methods
Subjects and randomization
Twenty-eight (14 women) physically active subjects aged
18–35 years were included in this exploratory double-
blind RCT. The subjects were students at the Faculty of
Medicine, Lund University or staff members at Malmö
University Hospital. They were enrolled by one of the
researchers. Subject characteristics, including activity level
[30] and self-reported outcomes assessed by the Knee
injury and Osteoarthritis Outcome Score (KOOS) [31,32],Page 2 of 9
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major orthopedic lesions, such as knee injury or fracture,
and allergic reactions to anesthetic agents. The physical
activity and age distribution of the subjects in this study
were chosen in order to match patients with ligament
injuries in the knee. Individuals with ligament injuries to
the knee are usually young, aged 18 to 35 years, and phys-
ically active at a moderate to high level [1,3]. The subjects
were randomly allocated, using a random number gener-
ator, to temporary anesthesia using a local anesthetic
cream (EMLA®) (EMLA group) or a placebo cream (oil and
water emulsion) (placebo group). To ensure an equal
number of men and women in each group two computer-
generated randomization lists, one for women and one
for men, were drawn up by a biostatistician and given to
the assessor. The assessor allocated the next available
number on entry into the trial, assigning the subjects to
treatment/placebo. The Research Ethics committee of
Lund University approved the study, and all subjects gave
their written informed consent.
Protocol and masking
Fourteen subjects received a local anesthetic cream con-
taining 2.5% lidocaine and 2.5% prilocaine (EMLA®,
AstraZeneca, Södertälje, Sweden) and 14 subjects received
a placebo cream of an oil and water emulsion (DAX, Opus
Health Care Inc., Malmö, Sweden). The two creams were
identical in color, consistency and packaging. A staff
member not participating as an assessor or subject in the
study distributed the packages with cream to the assessor.
Fifty grams of EMLA, or placebo [29], was applied circum-
ferentially on the leg 10 cm above and 10 cm below the
center of patella, leaving the area around the knee without
cream (Figure 1). The skin areas where the EMLA/placebo
was applied were covered with film wrap and a Tubigrip®
stocking (MEDLOCK Medical, Oldham, UK). After 90
minutes, during which time the subject was seated, the
EMLA/placebo was carefully washed off. The test leader
and the subjects were blinded to group allocation, and the
subjects were told not to reveal any possible anesthetic
sensation. Therefore, the presence or absence of anesthe-
sia was not verified by the assessor or the subject. The suc-
cess of blinding was not evaluated.
Outcome measures
Measures of sensory and motor functions were assessed
before and after 90 minutes of treatment with EMLA or
placebo. The tests were performed in the order that they
are described below. EMLA/placebo was applied and all
tests were performed on the right leg only. The assessment
took place at the Department of Orthopedics, Malmö
University Hospital. An experienced assessor, who was
well trained in all outcome measures from previous stud-
ies and pilot-testing preceding the present study, per-
formed the measurements.
Measures of sensory function
Three measures of sensory function were used; perception
of touch, vibration sense and knee kinesthesia. Lower val-
ues in these tests indicate better sensory function.
Perception of touch
Semmes-Weinstein monofilaments (SWM) were used for
assessing perception of touch at the most prominent
point of the medial femoral condyle, just proximal of the
joint space. Prior to the test, the SWM (nr 4.31, 2.0 g) was
demonstrated on the patient's styloid process of the hand,
so that the subjects could familiarize themselves with the
test. Thereafter, the subjects lay in a supine position and
were asked to close their eyes, concentrate on their knee
and respond when they felt any sensation of touch. The
assessment was performed according to a standardized
procedure [33]. Each monofilament, starting with the
thinnest and continuing with thicker until response to
sensation, was applied perpendicular to the skin for 1.5
seconds and lifted 1.5 seconds. The filament was applied
3 times to the same spot and was bent each time to exert
the specific pressure. Feeling the monofilament was
Table 1: Characteristics of the subjects.
Characteristic EMLA group (n = 14) Placebo group (n = 14)
Age (y)a 27 (4.8) 25 (3.9)
Women (n) 7 7
BMIa 23.0 (2.4) 24.2 (1.8)
Tegner activity levelb 5.5 (4 – 8) 5 (4 – 8)
KOOS subscales
Pain 100 (1.6) 98 (3.7)
Symptoms 99 (2.1) 98 (5.2)
ADL 100 (0.8) 100 (0.3)
Sport/Rec 98 (4.7) 99 (3.1)
QOL 97 (6.3) 95 (6.5)
aMean (SD), bmedian (quartiles), BMI; body mass index. The Tegner Activity Scale, ranges from 0 to 10, least to hardest strenuous activity for the 
knee. A Tegner activity level of 4 is equal to recreational sports such as jogging, aerobics, or cross-country skiing and a Tegner activity level of 5 is 
equal to recreational sports such as orienteering or down-hill skiing.Page 3 of 9
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identified by the patient [33].
Vibratory perception threshold
Vibratory perception threshold (VPT) was assessed by a
biothesiometer (Bio-Medical Instrument, Newbury, OH,
USA), according to the manufacturers' manual and previ-
ously published methods [34]. Prior to the test, the Bioth-
esiometer was demonstrated on the patient's styloid
process of the hand, so that the subjects could familiarize
themselves with the test. Thereafter, the subjects lay in a
supine position and were asked to close their eyes, con-
centrate on their foot/knee and respond when they felt
any sensation of vibration. The biothesiometer tip was
held with uniform pressure at two sites: the most promi-
nent point of the medial malleolus and the medial femo-
ral condyle (same location as that for testing perception of
touch). Three consecutive measurements were taken on
each site, and the amplitude was replaced to zero between
each measurement without moving the biothesiometer
tip from the location. The amplitude was increased by 1
Volt per second until the subjects responded to a sensa-
tion of vibration. This was noted as the VPT. The first
measurement was regarded a trial test, and was, thus,
excluded from the analysis. If the difference between the
second and third measurement was more than 20%, 2
additional tests were taken. The mean of the second and
third, or fourth and fifth, measurements was used in the
analysis. High reliability has been reported for the Bioth-
esiometer in healthy subjects [34,35].
Knee kinesthesia
Kinesthesia was measured in a specifically designed appa-
ratus, which has been used and described in detail in pre-
vious studies, see for example [36,37]. The subjects lay in
a lateral decubitus position, were asked to close their eyes,
concentrate on their knee and respond when they felt any
sensation of movement in their knee. Measurements of
the threshold for detection of passive motion (TDPM)
were performed towards knee extension (TE) and knee
flexion (TF) from the starting position of 20° knee joint
flexion, giving the variables TE20 and TF20. The median
values of three consecutive measurements of these two
variables were determined. The variables from the 20°
starting position (TE20 and TF20) have been found to be
reliable in uninjured subjects [38]. The sum of TE20 and
TF20, giving an index value, was used for statistical analy-
sis.
Measures of motor function
Two measures of motor function were used; the one-leg
hop test for distance and isokinetic knee muscle strength.
Higher values in these tests indicate better motor func-
tion.
One-leg hop test for distance
The one-leg hop test for distance with the arms free, aim-
ing at a more functional execution of the hop, was used.
The one-leg hop test is widely used for predicting func-
tional knee stability [1,3]. Muscle strength, balance and
confidence in the knee are contributing factors to the per-
formance of this test. The subjects were told to hop as far
as possible, taking off and landing on the same foot,
maintaining their balance for about 2–3 seconds. The test
was performed three times with each leg, alternating the
right and left leg, the hop distance being measured (in
cm) from toe in the starting position to heel in the landing
position. If the subject improved more than 10 cm
between the second and third hop, additional hops were
performed until an increase of less than 10 cm was meas-
ured. A trial one-leg hop preceded the measurements. The
subjects wore shoes, e.g., sneakers. The mean value of the
three best hops was used in the analysis. The reliability of
this test is high in uninjured subjects [39].
Isokinetic knee muscle strength
Measurements of concentric isokinetic strength of the
knee muscles were performed with a Biodex Multi-Joint
System III isokinetic dynamometer (Biodex Medical Sys-
tems Inc., Shirley, New York, NY, USA) with Biodex
Advantage software, version 4.0. The standard Biodex
knee unit attachment was used. Subjects were placed in an
upright position with 90° hip flexion on the Biodex
dynamometer chair, and were secured with straps across
the chest, pelvis, thigh and ankle. The resistance pad was
placed as distally as possible on the tibia while still allow-
ing full dorsiflexion at the ankle. The center of motion of
the lever arm was aligned as accurately as possible with
the slightly changing flexion-extension axis of the knee
joint. The range of motion of the knee joint was set at 5 to
90°. The subjects had their arms crossed over the chest
during the test. Standardized verbal instructions and
encouragement were given. The subjects were allowed
trial tests in order to familiarize themselves with the
Application of local anesthetic or placebo creamFigure 1
Application of local anesthetic or placebo cream. 
EMLA, or placebo, applied on the leg 10 cm above and 10 cm 
below the center of patella, leaving the area around the knee 
without cream.Page 4 of 9
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reciprocal concentric isokinetic knee extensions and flex-
ions at an angular velocity of 60°·s-1 were made. Peak
torque/body weight (Nm) was used in the analysis. High
test-retest reliability has been reported for isokinetic test-
ing at 60°·s-1 using the Biodex dynamometer [40].
Statistical analysis
The number of subjects needed was determined by an a
priori sample size calculation. No primary outcome meas-
ure was determined, since the study has an exploratory
character. We expected to find an improvement in more
than one of the variables to interpret the results as an
effect from treatment. For knee kinesthesia, sample size
calculations revealed that at least 12 subjects were needed
to detect an improvement by treatment of 30% within
groups (SDdiff 0.49), with 80% power at the 5% signifi-
cance level. For vibration sense, 13 subjects were needed
to detect an improvement of 20% (SDdiff 3.3) within
groups. For the one-leg hop test, and knee extension peak
torque, 2 and 5 subjects, respectively, were needed to
detect an improvement by treatment of 10% within
groups, with 80% power at the 5% significance level.
Based on these sample-size calculations, we included 28
subjects. The paired t-test was used for comparisons
within groups and the independent t-test for comparisons
between groups. All variables had Shapiro-Wilk statistic of
>0.90, except knee kinesthesia. The results were con-
firmed using non-parametric statistics. Wilcoxon signed
rank test, or Mann-Whitney test, was used for ordinal data
(perception of touch). Fischer's exact test was used for
between-group comparisons in the number of patients
with improvement by treatment. Effect size was calculated
by taking the difference between the means before and
after EMLA/placebo and dividing it by the SD of the same
measure before EMLA/placebo [41]. An effect size of
<0.50 was considered small, 0.50 to 0.79 moderate, and
≥0.80 large [41]. A level of p ≤ 0.05 was chosen to indicate
statistical significance. Group allocation was concealed to
the person analyzing the data, until the results were com-
pleted.
Results
No statistically significant or clinically relevant differences
were seen over time (before vs. after) in the measures of
sensory or motor functions in the EMLA group or in the
placebo group. There were no differences between the
groups due to treatment effect (EMLA vs. placebo)
(Table 2).
Sensory function before and after treatment with EMLA or 
placebo
No differences were found between assessments (before
vs. after) for perception of touch, vibration sense, or
kinesthesia in the EMLA group. No differences were found
before vs. after treatment for perception of touch, or vibra-
tion sense in the placebo group. A lower value for TDPM,
indicating better knee kinesthesia, was found after com-
pared with before treatment in the placebo group (p =
0.026). There were no differences between the groups in
effects of treatment for the measures of sensory function
(Table 2). The effect sizes were generally small in the
EMLA group (between 0.02 and 0.44) and in the placebo
group (between 0.11 and 0.56).
Motor function before and after treatment with EMLA or 
placebo
No differences were found between assessments (before
vs. after) for the one-leg hop test, knee extension or flex-
ion muscle strength in the EMLA group or placebo group.
There were no differences between the groups in effects of
treatment for the measures of motor function (Table 2).
The effect sizes were generally small in the EMLA group
(between 0.03 and 0.19) and in the placebo group
(between 0.05 and 0.15).
Discussion
In this first exploratory study on principles of brain plas-
ticity in improving sensorimotor function of the knee, we
found no effect of temporary anesthesia of the skin area
above and below the knee on sensorimotor function of
the ipsilateral knee and leg in uninjured subjects.
Although self-reported and objective function is
improved by neuromuscular and/or strength training, it is
unclear whether sensorimotor function can be fully
restored after knee injury and knee OA. In a recent study,
we found that at least one-third of patients with anterior
cruciate ligament (ACL) injury or reconstruction had not
recovered normal muscle function 2 to 5 years after injury
[42]. Possible reasons for this may be that the injury
causes a disturbance in the sensory system [43] with pos-
sible effects on the central mechanisms and motor
response [1], and/or that neuromuscular and strength
training programs are not sufficiently effective in improv-
ing or restoring sensorimotor function. Moreover, it has
been questioned whether training after knee injury can
lead to improvement in sensory function although
improvement in motor function can be obtained [44,45].
Good sensorimotor function is of importance for the
overall outcome after injury [6] and in preventing OA
[2,8]. Although improvements are achieved by neuromus-
cular and/or strength training, impairment in sensorimo-
tor function often persists [1-3]. Thus, it can be argued
that training programs need to be more effective in order
to improve or restore sensorimotor function after knee
injury and knee OA. Hypothetically, the principle of tem-
porary cutaneous anesthesia of adjacent body parts in
combination with training, that has been shown to be
more effective in improving sensorimotor function of the
hand than training only [28], could also be used toPage 5 of 9
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is that the selective anesthesia does not affect motor func-
tion of the leg. Thus, the individual can use the leg during
training while parts of the leg are anesthetized.
The only difference that we found was a lower value for
TDPM, indicating better knee kinesthesia, after compared
with before treatment in the placebo group. However, the
95% CI was close to zero (Table 2), indicating a small
change. Moreover, in a previous study on test-retest relia-
bility, we found that there may be a learning effect in
TDPM, shown as a significantly lower value in TDPM on
the second test session than on the first test session. In
that study, the 95% CI was also quite close to zero and,
therefore, we questioned the clinical relevance of this
learning effect [38]. Since the 95% CI in the current study
was close to zero and our previous study show that there
may be a learning effect in TDPM, the clinical relevance of
the improvement of 0.40 degrees (95% CI -0.05, -0.73),
can be questioned.
There may be several reasons for the lack of effect from
temporary cutaneous anesthesia of the skin area above
and below the knee on sensorimotor function of the ipsi-
lateral knee and leg in the uninjured subjects in our study.
Sensorimotor function may not be impaired in uninjured
subjects. Thus, the chance of achieving an improvement
in sensorimotor function in these subjects by the short-
term intervention that we used is most likely limited. For
example, a ceiling effect was noted in some of the meas-
ures. The subjects in our study had low values (good sen-
sory function) for both knee kinesthesia and skin
sensitivity before EMLA/placebo, limiting the chance of
improving these measures by treatment. In addition, the
effect sizes were generally small, indicating that the mag-
nitude of change by treatment was small. In previous stud-
Table 2: Results for outcomes of sensory and motor functions in the EMLA and placebo groups.
EMLA group Placebo group EMLA vs. 
placebo
Before Mean 
(SE)
After Mean 
(SE)
Mean diff 
(95% CI)
(after minus 
before)
Before Mean 
(SE)
After Mean 
(SE)
Mean diff 
(95% CI)
(after minus 
before)
Mean diff 
(95% CI)
(EMLA minus 
placebo)
Sensory 
function
Vibration sense 11.46 13.11 1.65 10.61 10.96 0.35 1.29
med mall (Volt) (0.99) (1.27) (-0.54, 3.82) (0.84) (0.69) (-0.70, 1.41) (-1.02, 3.59)
Vibration sense 19.64 21.25 1.61 16.57 17.75 1.18 0.43
med fem cond 
(Volt)
(1.71) (1.48) (-2.12, 5.33) (1.34) (1.30) (-0.79, 3.15) (-3.58, 4.44)
Knee 
kinesthesia
2.23 1.95 -0.28 1.88 1.48 -0.40 0.11
(degrees) (0.38) (0.45) (-1.00, 0.43) (0.19) (0.11) (-0.05, -0.73) (-0.65, 0.86)
Perception of 
touch
0.04 0.04 p = 0.646 0.07 0.07 p = 0.125 p = 0.265 
(before)
(grams) (0.008, 0.22) (0.008, 0.16) (0.04, 0.4) (0.02, 0.16) p = 0.769 (after)
Motor 
function
One-leg hop 
(cm)
134.56 135.21 0.65 144.14 146.05 1.91 -1.25
(6.85) (6.31) (-3.17, 4.48) (9.47) (9.79) (-3.47, 7.28) (-7.53, 5.03)
Knee ext peak 246.81 239.62 -7.19 252.66 246.73 -5.93 -1.26
torque/body 
weight (Nm)
(9.90) (11.10) (-16.26, 1.89) (10.40) (12.89) (-17.21, 5.35) (-15.03, 12.52)
Knee flex ext 
peak
129.56 128.30 -1.26 134.66 136.54 1.88 -3.14
torque/body 
weight (Nm)
(7.43) (7.41) (-6.66, 4.15) (7.24) (7.88) (-3.83, 7.59) (-10.61, 4.34)
Mean and standard error (SE) and mean difference (95% CI) (after minus before) for the tests of sensory function (vibration sense, kinesthesia) and 
motor function (one-leg hop test, knee extension and flexion peak torque/body weight) before and after treatment with EMLA/placebo, and mean 
difference (95% CI) (EMLA minus placebo) between the EMLA and placebo groups (t-test). Median (quartiles) and p-value (Wilcoxon singed rank 
test, Mann-Whitney test) given for perception of touch (ordinal data).
Med mall = medial malleolus, Med fem cond = medial femoral condyle, Ext = extension, Flex = flexionPage 6 of 9
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higher values (poorer kinesthesia) than uninjured sub-
jects [44,37]. Thus, the possibility of improving kinesthe-
sia by temporary cutaneous anesthesia may be greater in
subjects with knee injury than in uninjured subjects. We
tested one site for perception of touch, while several sites
were tested in the corresponding study of the foot [29]. In
an effort to reduce the ceiling effect, several sites around
the knee could be tested in further studies. However, the
perception of touch of the knee is not as delicate and dis-
criminative as in the hand or the foot sole. Thus, large
effects from temporary cutaneous anesthesia may be
needed to detect a change in perception of touch of the
knee. Due to the exploratory character of our study, the a
priori sample size calculation was based on predictions. A
post-hoc sample size calculation estimated that about 30
subjects in each group would be needed to detect
improvement in the EMLA group compared with the pla-
cebo group for the measures of sensory function and
between 5 and 9 subjects in each group for the measures
of motor function, with 80% power at the 5% significance
level. Thus, the risk of a type II error in the present study
cannot be ruled out, implying a need for a larger group of
subjects in further studies.
It is well known from animal and human experiments
that temporary cutaneous anesthesia of one body part
leads to cortical re-organization resulting in a correspond-
ing silent area in the sensory cortex. This allows adjacent
nearby body parts to rapidly expand at the expense of the
silent cortical area [21,22]. Previous studies on the upper
and lower extremity [27-29] as well as the present study
have been done on subjects without pain. A peripheral
nociceptive stimulus, e.g., a painful knee, is known to
induce plasticity changes in the spinal cord and at subcor-
tical and cortical levels. Thus, treating patients with a
painful joint using cutaneous deafferentation may give a
different result compared to that for individuals without
pain. This needs to be addressed in future studies. Neuro-
physiologic mechanisms in the lower extremity may also
differ from those in the upper extremity. Large overlaps in
the sensorimotor activation have been shown following
movement of the knee, ankle and toes as opposed to the
fingers [46]. However, the same plasticity mechanisms
likely occur in both the upper and lower extremity, thus
making it possible to manipulate plasticity mechanisms
also in the lower extremity in order to improve sensorim-
otor function.
In previous studies on the upper extremity [27,28], the
anesthetic cream was applied to the volar aspect of the
forearm and in the previous study on the lower extremity
the anesthetic cream was applied circumferentially on the
lower leg [29]. Based on these previous studies, it would
be logical to deafferentate the foot and lower leg in the
current study. However, it is very difficult to anesthetize
the entire foot using EMLA due to problems with absorp-
tion of the EMLA in the sole of the foot and applying an
occlusive bandage. Therefore, we decided to anesthetize
the skin area adjacent to the knee knowing that following
deafferentation, the adjacent cortical areas rapidly occupy
the anesthetized area. We also decided to deafferentate cir-
cumferentially on the lower extremity because the cortical
area devoted to the lower extremity is small compared to
the hand and we, therefore, expected that a larger deaffer-
entated skin area was needed (compared to the upper
extremity) in order to allow the knee to expand in the pri-
mary somatosensory and motor cortex.
We believe that the amount of EMLA that we used (50
grams) and placing of the anesthetic cream (above and
below the knee) is adequate in order to expect an
increased cortical knee representation. However, the corti-
cal area of the knee is smaller than the cortical area of the
hand [17,18]. Thus, larger effects of treatment are needed
in order to detect an increase in the cortical area of the
knee than in that of the hand. In line with this reasoning,
we found no effect of temporary cutaneous anesthesia of
adjacent body parts in the measures of sensory or motor
functions of the knee in healthy subjects, whereas previ-
ous studies reported improvement in sensory function of
the hand and foot in healthy subjects after such treatment
[27,29]. This could be due to lack of cortical re-organiza-
tion following the cutaneous anesthesia or that the re-
organization was too small to result in a detectable
improvement. However, we did not investigate whether
the lack of improvement in these measures corresponds to
a lack of cortical re-organization. In further studies, neu-
roimaging methods, such as functional magnetic reso-
nance imaging, can be used to address this question.
Due to the loss of mechanoreceptors after knee injury, the
sensory system is disturbed [43], possibly causing effects
on sensory and motor functions. Thus, treatment leading
to improved sensorimotor function would be of value for
patients with knee injury. In line with observations in
individuals with hand nerve injury, the sensory deficiency
after knee injury can, at least hypothetically, be associated
with functional re-organization of the somatosensory cor-
tex of the brain. Thereby, it can be argued that the princi-
ple of temporary cutaneous anesthesia in improving
sensorimotor function can be used also on the knee. In
current neuromuscular training programs for patients
with knee injury, principles of brain plasticity such as
training of the contralateral extremity are included [1,3].
The aim of these neuromuscular training programs is to
enhance unconscious motor responses by stimulating
both afferent signals and central mechanisms responsible
for dynamic joint control [47,1]. From the present study,
we cannot exclude that there is no effect of temporaryPage 7 of 9
(page number not for citation purposes)
BMC Musculoskeletal Disorders 2009, 10:99 http://www.biomedcentral.com/1471-2474/10/99cutaneous anesthesia of the skin area above and below the
knee on sensorimotor function of the ipsilateral knee and
leg in uninjured subjects. However, based on the reason-
ing above, studies on the effect of temporary cutaneous
anesthesia for improving sensorimotor function in
patients with knee injury and functional limitations are
warranted.
Conclusion
In this exploratory randomized study, we found no effect
of temporary cutaneous anesthesia on sensorimotor func-
tion of the ipsilateral knee and leg in uninjured subjects.
The principles of brain plasticity used in this study remain
to be tested in subjects with knee injury and functional
limitations.
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